What Fassisi GmbH does

Fassisi GmbH, founded in 2010 and headquartered in the Göttinger Biotechnologiepark (Marie-Curie-Strasse 8, 37079 Göttingen, Germany), is a specialized German manufacturer and developer of point-of-care lateral flow immunoassay (rapid test) systems for veterinary diagnostics. The company produces a portfolio of more than 50 individual rapid test kits covering companion animals (dogs and cats — including Parvo, Corona, FIV, FeLV, Giardia, Leishmania, Lyme, distemper, and vaccination titer tests), large animals (cattle, calves, pigs, lambs, horses, foals — including BoDia variants, BoviPreg for bovine pregnancy, Bovine IgG for passive immunity, PiDia, TetaCheck), and environmental/other applications (BoTick for Borrelia detection in ticks, AllerBovine for bovine allergen detection). The technology platform is built on three proprietary differentiators: the Fassisi-tag (enhanced test performance tag used in products such as FeLFIV), Blue Latex Detection Technology (used in Giardia tests for clearer visual reading), and a Multiplex platform enabling simultaneous detection of multiple pathogens in a single test.

The company operates under audited international quality standards including ISO 9001:2015, GMP certification, and holds manufacturer permits under both §13 AMG (Arzneimittelgesetz) and TierSG (Tierseuchengesetz), a combination that is rare among veterinary rapid test providers. Manufacturing takes place at the Göttingen facility, which was expanded in December 2020 with relocation to larger premises within the Science Park III biotechnology cluster.

Fassisi's revenue model is built on two streams: (1) one-time sales of branded rapid diagnostic test kits through veterinary wholesalers and distribution partners (Vertriebspartner) across Germany, Austria, and Switzerland, supplemented by direct sales via the Fassisi online shop with free domestic shipping above €40; and (2) a smaller professional services stream offering contract development and manufacturing (Auftragsentwicklung) for animal health companies and research institutions requiring custom test development leveraging Fassisi's platform technologies. The company maintains a wholly-owned Austrian subsidiary, Fassisi AT GmbH (established 2017), which distributes specific product lines (T4, Equine IgG, TetaCheck, BoviPreg, Bovine IgG, CanTi Check, CantiCheck Plus) into Austria. GTM is multi-channel: B2B sales-led targeting veterinarians in small and large animal practice, channel partner distribution, and event-driven demand generation with active participation in major veterinary congresses (Leipziger Tierärztekongress, DeutscheVET, bpt-Kongress). The company is privately held with no institutional investor or public market involvement disclosed.

Name

Fassisi GmbH

Legal name

Fassisi, Gesellschaft für Veterinärdiagnostik und Umweltanalysen mbH

Website

https://fassisi.de

Company type

Private

Founded year

2010

Operating status

Operating

Headcount range

1–10 employees

Short description

Fassisi GmbH is a Göttingen, Germany-based manufacturer of point-of-care lateral flow rapid diagnostic tests for veterinary use, serving veterinarians and livestock farmers across the DACH region with a portfolio of more than 50 consumable test kits for companion animals, livestock, and equine applications.

Ownership category

akta.pro rank

Product category

Veterinary Diagnostics

NAICS

Veterinary Services (54194), Support Activities for Animal Production (1152)

SIC

In Vitro & In Vivo Diagnostic Substances (2835), Biological Products, (No Disgnostic Substances) (2836)

akta.pro primary industry

Veterinary POCT & Rapid Diagnostics (Animal health rapid tests) (HLAHAOAL)

akta.pro secondary industries

Veterinary Microbiology & Infectious Disease Testing (Culture/PCR/Serology) (HLAMADAC), Veterinary Parasitology Testing (HLAMADAD), Diagnostics & Laboratory Services (Sampling, Necropsy, Disease Investigation) (AFACADAF), Endocrinology & Metabolic Drugs (e.g., Diabetes, Thyroid) (HLAMAEAG)

Keywords

• Veterinary diagnostic tests
• Rapid immunoassay tests
• Lateral flow assays
• Animal health diagnostics
• Point-of-care testing

Headquarters

HQ city

Göttingen

HQ country

Germany

HQ region

Europe

Offices2 records

Markets served

GTM type

B2B

Offering type

Hardware or Manufacturing

Cost components

Personnel, Operations, Supply Chain, Technology or R&D, Marketing or Sales, Infrastructure

Revenue model

1. Veterinary Rapid Test Products: One-time sale of rapid diagnostic test kits for veterinary use. Products are sold to veterinarians (Tierärzte) and livestock farmers through veterinary wholesalers, distribution partners, and directly via the Fassisi online shop. The product range covers point-of-care tests for small animals (cats, dogs) and large animals (cattle, calves, pigs, lambs, horses, foals).
2. Contract Development Services: Custom test development and manufacturing services (Auftragsentwicklung) for customer-specific parameters. Fassisi offers full in-house development and production, leveraging their platform technologies and experience with various species and sample materials. This represents a professional services / project-based revenue stream.

Pricing tiers

Go-to-market motion3 records

Distribution channels3 records

Marketing channels4 records

Core offering

Fassisi GmbH develops, manufactures, and distributes veterinary in-vitro rapid diagnostic test kits (lateral flow immunoassays) for point-of-care use by veterinarians and livestock producers. The portfolio spans companion-animal pathogen tests (e.g., Parvo, Corona, Giardia, FeLV/FIV, Leishmania, Ehrlichia), canine vector-borne disease panels, and livestock tests for reproductive status, metabolic disorders, passive transfer, and allergen exposure (e.g., BoviPreg, PiDia, Bovine IgG, TetaCheck, AllerBovine). The company also offers contract development and OEM manufacturing services for external animal-health clients.

Product overview

Fassisi GmbH is a German manufacturer and developer of veterinary diagnostic rapid test systems based in Göttingen, Germany. The product portfolio consists of rapid test systems organized into three main categories: products for large animals (cattle, calves, pigs, lambs, horses, and foals), products for small animals (dogs and cats), and environmental/other products. The core technology platform includes the Fassisi Multiplex system enabling multiplex detection. For large animals, key products include BoDia (and its variants: MPX, Advance MPX, Plus, +Gia) for diarrhea pathogens, BoviPreg for bovine pregnancy detection, Bovine IgG for passive immunity assessment, PiDia/PiDia Light for young animal pathogens, and TetaCheck for equine tetanus antibody titers. For small animals, the portfolio includes pathogen-specific tests (Parvo, Corona, FIV, FeLV, GiarDia, LymeBo, EhrCanis, LeishMa, CanDis, CanDiro), combination tests (ParCo, Triple, FeLFIV), and advanced multiplex products (CanVecto 3, CanVecto 4, CantiCheck Plus). The BoTick detects Borrelia in ticks, and AllerBovine detects bovine allergens in dust. The company also offers contract development services for custom diagnostics.

Differentiator

Problem solved

Functional benefit

Brands

• Fassisi-tag: Proprietary technology used in Fassisi rapid tests for enhanced test performance and accuracy.

Products and services

• Fassisi Multiplex test platform Proprietary platform combining multiple veterinary pathogen detections in a single lateral flow test, used as the technological basis for the BoDia, Giardia+CPE, and Triple family products.
• BoDia (canine Giardia + blood-detection add-on) Rapid in-clinic test for detection of Giardia antigen in dogs, with MPX/Advance MPX/Plus variants adding additional combined antigen detection for the same sample.
• ParCo (Parvovirus + Coronavirus double test) Rapid in-clinic test that simultaneously detects canine Parvovirus and Coronavirus antigens in fecal samples for differential diagnosis of acute diarrhea in dogs.
• Parvo (canine Parvovirus single test) Rapid in-clinic antigen test for canine Parvovirus in fecal samples, used for confirming parvoviral enteritis in dogs.
• Corona (canine Coronavirus single test) Rapid in-clinic antigen test for canine Coronavirus in fecal samples.
• GiarDia (canine Giardia single test) Rapid in-clinic antigen test for Giardia in canine fecal samples, with a later latex-enhanced version (GiarDia Latex) launched in March 2013.
• Giardia+CPE / Giardia+CPE MPX Multiplex rapid test for combined detection of Giardia and Clostridium perfringens enterotoxin (CPE) in canine fecal samples.
• CryGiDia / CryGiDia MPX Rapid antigen test detecting Cryptosporidium and Giardia simultaneously in canine fecal samples.
• Triple / Triple MPX Multiplex rapid test combining detection of three companion-animal pathogens (e.g., Parvo/Corona/Giardia) in a single test cassette.
• ThyroControl Cat / T4 Rapid in-clinic semi-quantitative test for total thyroxine (T4) in cats, used for screening and monitoring hyperthyroidism.
• FeLV (Feline Leukemia Virus test) Rapid in-clinic antigen test for Feline Leukemia Virus (FeLV p27 antigen) in cat blood samples.
• FIV (Feline Immunodeficiency Virus test) Rapid in-clinic antibody test for Feline Immunodeficiency Virus (FIV) in cat blood samples.
• FeLFIV (combined FeLV + FIV test with Fassisi-tag) Combined rapid test detecting both FeLV antigen and FIV antibody in cat blood samples using Fassisi-tag blue-latex detection technology.
• Feline Triple (Feline ParvoCheck + FeLV + FIV) Rapid in-clinic test combining feline panleukopenia (parvovirus) antigen detection with FeLV and FIV screening in cats.
• Feline ParvoCheck Rapid in-clinic antigen test for feline panleukopenia (feline parvovirus) in fecal samples.
• CanDis (canine Distemper test) Rapid in-clinic antigen test for canine Distemper virus (CDV) in ocular or nasal secretions.
• CanDiro (canine Dirofilaria test) Rapid in-clinic antigen test for Dirofilaria immitis (canine heartworm) in dog blood samples.
• LeishMa (canine Leishmaniasis test) Rapid in-clinic test for Leishmania infantum antibodies/antigens in dog blood samples.
• LymeBo (Lyme Borreliosis test) Rapid in-clinic antibody test for Borrelia burgdorferi (Lyme disease) in dog blood samples.
• EhrCanis (Ehrlichia canis test) Rapid in-clinic antibody test for Ehrlichia canis in dog blood samples.
• EhrLeish (Ehrlichia + Leishmania test) Rapid in-clinic antibody test for combined detection of Ehrlichia and Leishmania exposure in dogs.
• CanVecto Trio Rapid in-clinic antibody panel for combined detection of canine vector-borne pathogens (e.g., Ehrlichia/Anaplasma/Borrelia/Leishmania group) in dog blood samples.
• CanVecto 3 Rapid in-clinic three-parameter antibody panel for detection of canine vector-borne diseases in dog blood samples.
• CanVecto 4 Rapid in-clinic four-parameter antibody panel for detection of canine vector-borne diseases in dog blood samples.
• CantiCheck Plus / CantiCheck MPX Multiplex rapid test combining multiple antigen/antibody detections relevant to canine infectious disease screening in a single cassette.
• BoviPreg (bovine pregnancy test) Rapid on-farm pregnancy test for cattle, detecting pregnancy-associated glycoproteins in serum or plasma.
• Bovine IgG Rapid test for measurement of bovine IgG in serum or plasma to assess failure of passive transfer in neonatal calves.
• PiDia Rapid in-clinic test for fructosamine (glycated protein) in dog and cat serum, used for monitoring long-term glycemic control in diabetic patients.
• PiDia Light Streamlined version of the PiDia fructosamine test for diabetic monitoring in dogs and cats, with reduced workflow for routine practice use.
• TetaCheck (bovine ketone / metabolic test) Rapid on-farm test for detection of ketone bodies (β-hydroxybutyrate) in bovine milk or blood, used for subclinical ketosis screening in dairy cows.
• Equine IgG Rapid test for measurement of equine IgG in foal serum to assess failure of passive transfer in neonatal foals.
• AllerBovine (bovine allergen exposure test) Rapid test for detection of allergen-specific IgE antibodies in cattle, used to assess allergen exposure relevant to bovine allergic disease.
• BoTick (Babesia / Babesia spielmanii tick test) Rapid test for detection of Babesia antibodies (including B. spielmanii) in dog blood samples; revised version released July 2013.
• Contract Development Services Service offering under which Fassisi develops and OEM-manufactures custom lateral flow immunoassay veterinary diagnostic tests for external animal-health companies, leveraging the Fassisi-tag platform and GMP/§13 AMG-certified facility.

Quantifiable outcome

• CantiCheck Plus achieved 98.11% sensitivity and 99.99% specificity for CPV antibodies in an independent study (Viruses 2021), outperforming three other commercially available point-of-care tests.
• +1 more outcomes

Named customers2 records

Segments3 records

Ideal customer profiles3 records

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature5 records

Partnerships

Three partnerships are on record, tiered core and minor.

• Fassisi AT GmbHcoreOthers · 7 April 2017Fassisi AT GmbH is a subsidiary of Fassisi GmbH based in Austria. It distributes specific Fassisi products in the Austrian market and serves as the Austrian sales and distribution entity. Products distributed include Fassisi T4, Equine IgG, TetaCheck, BoviPreg, Bovine IgG, CanTi Check, and CantiCheck Plus.
• Veterinary Distributors / Wholesalers (Vertriebspartner)coreChannel Partner/ Reseller/ DistributorFassisi sells all products through veterinary distribution partners (Vertriebspartner). These partners distribute Fassisi rapid tests across Germany, Austria, Switzerland, and other German-speaking markets. Distribution partners are the primary route to market for reaching veterinarians and livestock farmers.
• Scientific Partner NetworkminorStrategic or Co-development PartnerFassisi maintains a network of scientific partners for handling complex diagnostic questions in custom development projects. This network supports the company's Auftragsentwicklung (contract development) services, enabling development of tests for complex parameters and applications.

Scale indicators3 records

Recent moves6 records

Expansion highlights5 records

Broad incumbents

• Virbac: Global animal health company with a diagnostics portfolio including rapid tests for companion animals and livestock. Virbac's broader pharmaceutical and vaccine offering makes it a broad incumbent that overlaps with Fassisi's on-farm and clinic-based rapid testing.
• Heska (Mars Petcare): Now part of Mars Petcare, Heska sells point-of-care veterinary diagnostics including in-clinic analyzers and rapid test kits for companion animals. The company competes most directly with Fassisi's small animal lateral flow portfolio while also operating broader diagnostic platforms.
• IDEXX Laboratories: Global leader in veterinary diagnostics with reference lab services and in-clinic analyzers (Catalyst Dx, ProCyte Dx, SNAP rapid tests). Comparable because SNAP rapid tests directly compete with Fassisi's lateral flow portfolio in companion animal practice, though IDEXX operates at much greater scale and across a broader diagnostics portfolio.
• Zoetis: Largest global animal health company offering diagnostics, vaccines, and pharmaceuticals. Zoetis's Vetscan rapid test suite and reference lab services overlap with Fassisi's companion animal and livestock offerings, though Zoetis competes across a much broader portfolio and at significantly greater scale.

Emerging players

• Alvedia: French veterinary diagnostics company specializing in rapid blood typing tests for companion animals. Comparable to Fassisi as a focused European veterinary rapid test manufacturer, though Alvedia operates in a narrower niche (blood typing) than Fassisi's broader infectious disease portfolio.

Direct peers

• Eurolyser Diagnostica: Austrian manufacturer of point-of-care veterinary diagnostic tests and analyzers with a focus on small animal and livestock practice. Closely comparable to Fassisi on technology (lateral flow POC), geographic focus (DACH/Austria), and customer base (veterinary practices and laboratories).
• INDICAL BIOSCIENCE: Germany-based developer and manufacturer of veterinary diagnostics, including rapid tests and PCR kits for companion animals and livestock. Highly comparable to Fassisi as a German-headquartered veterinary diagnostics manufacturer serving similar European markets with overlapping product categories.
• Innovative Diagnostics (IDvet): French veterinary diagnostics manufacturer specializing in ELISA kits and rapid tests for livestock and companion animals. Comparable to Fassisi as a focused veterinary diagnostics manufacturer with B2B distribution to veterinary practices and labs, though IDvet is larger and more export-oriented.
• Scil Animal Care: German-based veterinary diagnostics company offering in-clinic analyzers and rapid tests for companion animals and livestock. Direct peer to Fassisi given similar German-speaking market focus, B2B distribution model, and rapid test product portfolio.
• MEGA COR Diagnostik: Austrian veterinary diagnostics company selling the FASTest brand of rapid in-clinic tests for companion animals and livestock. Direct peer to Fassisi given overlapping product portfolio (lateral flow POC), regional focus (DACH), and veterinary customer base.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat4 records

Key risks6 records

Key highlights6 records

Customer concentration

• Facebookfacebook.com/Fassisi-Deutschland-100784416070811
• Instagraminstagram.com/fassisi_de
• LinkedInlinkedin.com/company/fassisi

Compliance6 records

Revenue estimate

Valuation estimate

Number of profiles

Profiles2 records

Subsidiaries1 record

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Fassisi GmbH